company background image
4128 logo

Microbio TPEX:4128 Stock Report

Last Price

NT$34.40

Market Cap

NT$20.2b

7D

-7.3%

1Y

-27.2%

Updated

18 Dec, 2024

Data

Company Financials

4128 Stock Overview

Researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. More details

4128 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Microbio Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Microbio
Historical stock prices
Current Share PriceNT$34.40
52 Week HighNT$49.33
52 Week LowNT$31.38
Beta1.45
1 Month Change-0.58%
3 Month Change-15.48%
1 Year Change-27.18%
3 Year Change-36.19%
5 Year Change226.36%
Change since IPO259.71%

Recent News & Updates

Recent updates

Should You Use Microbio's (GTSM:4128) Statutory Earnings To Analyse It?

Jan 04
Should You Use Microbio's (GTSM:4128) Statutory Earnings To Analyse It?

Shareholder Returns

4128TW Personal ProductsTW Market
7D-7.3%-3.3%-0.6%
1Y-27.2%-19.5%28.5%

Return vs Industry: 4128 underperformed the TW Personal Products industry which returned -19.5% over the past year.

Return vs Market: 4128 underperformed the TW Market which returned 28.5% over the past year.

Price Volatility

Is 4128's price volatile compared to industry and market?
4128 volatility
4128 Average Weekly Movement4.2%
Personal Products Industry Average Movement3.9%
Market Average Movement4.5%
10% most volatile stocks in TW Market7.9%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 4128 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4128's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000n/aTzen-Wen Chenwww.twmicrobio.com

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services.

Microbio Co., Ltd. Fundamentals Summary

How do Microbio's earnings and revenue compare to its market cap?
4128 fundamental statistics
Market capNT$20.23b
Earnings (TTM)-NT$873.89m
Revenue (TTM)NT$1.68b

12.0x

P/S Ratio

-23.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4128 income statement (TTM)
RevenueNT$1.68b
Cost of RevenueNT$1.03b
Gross ProfitNT$648.19m
Other ExpensesNT$1.52b
Earnings-NT$873.89m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.49
Gross Margin38.54%
Net Profit Margin-51.96%
Debt/Equity Ratio0%

How did 4128 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 01:58
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Microbio Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Evana ChenMasterlink Securities Corp.